February 14, 2025 19:15 ET | Source:
February 14, 2025 18:20 ET | Source:
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/…
– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on…
– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on…
LYON, France, Feb. 11, 2025 /PRNewswire/ -- Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement…
February 10, 2025 Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading…
EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior vision gains with an every 8-week dosing regimen…
At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended…
February 07, 2025 16:58 ET | Source: Pliant Therapeutics, Inc. Following DSMB recommendation, the Company has voluntarily paused enrollment and…